Financials

  • Market Capitalization 210.12 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.86
Relación precio/flujo de caja
-167.18

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3589
CRBP
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
10.91 USD-1.98%+6.96%+22.58%-34.28%211.01 M USD
3591
ANTX
AN2 Therapeutics, Inc. - Common Stock
5.58 USD-2.79%-4.12%+10.93%+398.21%210.57 M USD
3594
ORMP
Oramed Pharmaceuticals Inc. - Common Stock
5.03 USD-1.37%+4.57%+25.75%+135.05%209.23 M USD
3596
IPHA
Innate Pharma S.A. - American Depositary Shares
2.23 USD0.00%+0.90%+27.43%+7.21%208.99 M USD

Noticias